Reckitt lowers sales forecast due to supply constraints in US and China
Summary
Reckitt has revised its sales forecast downwards due to supply constraints impacting its cleaning products in the US and a decline in sales of its vitamin brands in China. This situation reflects broader challenges faced by consumer goods companies, which are currently navigating temporary capacity limitations in North American production facilities. Additionally, the vitamins category in China has been experiencing slower demand due to changes in consumer spending patterns.
Analysis
Reckitt: Reckitt Benckiser Group plc is a British multinational consumer goods company that develops and markets health, hygiene, and nutrition products under brands such as Lysol, Dettol, Durex, and Mead Johnson. The company operates across multiple regions with a focus on power brands and emerging markets. In the latest quarterly results, Reckitt revised its full-year sales outlook lower due to temporary manufacturing constraints affecting Lysol supply in North America and softer performance in its vitamins category in China. China Category Trends: The vitamins, minerals, and supplements category has faced slower demand in China amid shifting consumer spending patterns. Manufacturing Constraints: Consumer goods companies are managing temporary capacity limitations at North American production facilities while upgrading capabilities to meet demand for hygiene products. Market Recovery Expectations: Companies in the sector anticipate rebounds in affected regions as supply issues are resolved and seasonal demand supports key brands.
Categories
macro
Related sources
- https://finchannel.com/reckitt-shares-fall-after-lysol-disruption-prompts-outlook-cut/139597/american-business-trends/2026/10/
- https://www.morningstar.com/news/dow-jones/202610271353/reckitt-cuts-outlook-after-lysol-issues-stunt-north-america-sales
- https://www.hl.co.uk/shares/stock-market-news/company--news/reckitt-cuts-full-year-sales-outlook-after-weaker-third-quarter
- https://www.reckitt.com/news/q3-results-2026/
- https://www.asktraders.com/analysis/reckitt-revises-growth-guidance-as-lysol-supply-limits-bite/
- https://www.thegrocer.co.uk/news/reckitt-benckiser-cuts-growth-forecasts-after-mixed-q3/725222.article
- https://www.rttnews.com/3703270/reckitt-q3-revenue-rises-cuts-annual-revenue-growth-outlook.aspx
- https://www.proactiveinvestors.com/companies/news/1100727/reckitt-trims-sales-growth-outlook-as-lysol-constraints-weigh-on-north-america-1100727.html
- https://www.reuters.com/business/healthcare-pharmaceuticals/reckitt-lowers-annual-revenue-growth-guidance-struggles-north-america-2026-10-27/